Magge, D <br/><br/>
A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases from colorectal cancer.  [electronic resource] 

 -  Annals of surgical oncology  Jul 2013 
 - 2180-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1534-4681 
<br/><br/><label>Standard No.: </label>10.1245/s10434-013-2960-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Area Under Curve<br/>Carcinoembryonic Antigen--blood<br/>Chemotherapy, Cancer, Regional Perfusion--adverse effects<br/>Colorectal Neoplasms--blood<br/>Disease-Free Survival<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Kaplan-Meier Estimate<br/>Liver Neoplasms--blood<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin